Please assess the completion status of the following clinical trial:

Trial Title: OCT-guided LALAK for KCN

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Eyes with keratoconus that cannot be adequately or safely corrected with spectacles, contact lens or excimer laser surface ablation. The cornea must have healthy endothelium (endothelial cell density \> 1,500/mm2).~Exclusion Criteria:~1. Preoperative corneal thickness less than 400 microns.~2. Corneal edema~3. Central guttata~4. Inability to give informed consent.~5. Inability to maintain stable fixation for OCT imaging.~6. Inability to commit to required visits to complete the study.~7. Eyes with concurrent cataract, retinal diseases, glaucoma, or other eye conditions that may limit the visual outcome after surgery.~8. Patients with severe collagen vascular diseases or ocular surface disorders

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 100 Years
- Healthy Volunteers: f

Study Arms:
- LALAK (Type: EXPERIMENTAL): laser-assisted lamellar anterior keratoplasty. Optical Coherence Tomography, femtosecond laser, topical anesthesia, and Retrobulbar Block or General Anesthesia will be used.
- IEK (Type: ACTIVE_COMPARATOR): Intralase-enabled keratoplasty. Femtosecond laser and Retrobulbar Block or General Anesthesia will be used.

Based on this trial design, predict the completion outcome and termination type (if applicable).